GRI Bio, Inc. (GRI) Financials
GRI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 11.3 million | 794000 |
| Dec. 31, 2025 | 8.7 million | 2.7 million |
| Sept. 30, 2025 | 4.8 million | 2.8 million |
| June 30, 2025 | 5.7 million | 2.4 million |
GRI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.7 million | 31000 |
| Dec. 31, 2025 | -3.0 million | 67000 |
| Sept. 30, 2025 | -2.3 million | 465000 |
| June 30, 2025 | -3.2 million | 41000 |
GRI Net Income
No data available :(
GRI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 11.0 million | - | 58000 |
| Dec. 31, 2025 | 8.2 million | - | 71000 |
| Sept. 30, 2025 | 4.1 million | - | 84000 |
| June 30, 2025 | 5.1 million | - | 96000 |
GRI Shares Outstanding
GRI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 361000 | 1.6 million | - |
| Dec. 31, 2025 | 3000 | 1.6 million | 1.0 million | - |
| Sept. 30, 2025 | - | 1.8 million | 1.6 million | - |
| June 30, 2025 | 396000 | 1.9 million | 1.0 million | - |
GRI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 1000 |
| Dec. 31, 2025 | - | 1000 |
| Sept. 30, 2025 | 6.3 million | 3.4 million |
| June 30, 2025 | 22.5 million | 1000 |
GRI
Price: $1.88
52 week price:
Earnings Per Share: 38.89 USD
P/E Ratio: 0.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2375
Market Capitalization: 180562